Literature DB >> 15577423

Genetic diversity of HIV type 1 in rural eastern Cameroon.

Nicaise Ndembi1, Jun Takehisa, Leopold Zekeng, Eiji Kobayashi, Charlotte Ngansop, Elijah M Songok, Seiji Kageyama, Taichiro Takemura, Eiji Ido, Masanori Hayami, Lazare Kaptue, Hiroshi Ichimura.   

Abstract

To monitor the presence of genotypic HIV-1 variants circulating in eastern Cameroon, blood samples from 57 HIV-1-infected individuals attending 3 local health centers in the bordering rural villages with Central African Republic (CAR) were collected and analyzed phylogenetically. Out of the 40 HIV-1 strains with positive polymerase chain reaction (PCR) profile for both gag and env-C2V3,12 (30.0%) had discordant subtype or CRF designation: 2 subtype B/A (gag/env), 1 B/CRF01, 2 B/CRF02, 1 CRF01/CRF01.A, 2 CRF11/CRF01, 1 CRF13/A, 1 CRF13/CRF01, 1 CRF13/CRF11, and 1 G/U (unclassified). Twenty-eight strains (70.0%) had concordant subtypes or CRF designation between gag and env: 27 subtype A and 1 F2. Out of the remaining 17HIV-1 strains negative for PCR with the env-C2V3 primers used, 10 (58.8%) had discordant subtype or CRF, and 7 (41.2%) had concordant one based on gag/pol/env-gp41 analysis. Altogether, a high proportion (22/57, 38.6%) of the isolates were found to be recombinant strains. In addition, an emergence of new forms of HIV-1 strains, such as subtype B/A (gag/env), B/CRF01 and B/CRF02, was identified. The epidemiologic pattern of HIV-1 in eastern Cameroon, relatively low and high prevalence of CRF02 and CRF11, respectively, was more closely related to those of CAR and Chad than that of other regions of Cameroon, where CRF02 is the most predominant HIV-1 strain. These findings strongly suggest that this part of Cameroon is a potential hotspot of HIV-1 recombination, with a likelihood of an active generation of new forms of HIV-1 variants, though epidemiologic significance of new HIV-1 forms is unknown.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577423     DOI: 10.1097/00126334-200412150-00019

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Reference values of lymphocyte subsets in healthy, HIV-negative children in Cameroon.

Authors:  Bertrand Sagnia; Francis Ateba Ndongo; Suzie Ndiang Moyo Tetang; Judith Ndongo Torimiro; Cristiana Cairo; Irenée Domkam; Geraldine Agbor; Emmanuel Mve; Olive Tocke; Emilien Fouda; Odile Ouwe Missi Oukem-Boyer; Vittorio Colizzi
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

3.  HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.

Authors:  Georgette D Kanmogne; Callixte T Kuate; Lucette A Cysique; Julius Y Fonsah; Sabine Eta; Roland Doh; Dora M Njamnshi; Emilienne Nchindap; Donald R Franklin; Ronald J Ellis; John A McCutchan; Fidele Binam; Dora Mbanya; Robert K Heaton; Alfred K Njamnshi
Journal:  BMC Neurol       Date:  2010-07-13       Impact factor: 2.474

4.  Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.

Authors:  Nicaise Ndembi; Awet Abraha; Heather Pilch; Hiroshi Ichimura; Dora Mbanya; Lazare Kaptue; Robert Salata; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

5.  Disease Progression in HIV-1-Infected Viremic Controllers.

Authors:  Katherine C Groves; David F Bibby; Duncan A Clark; Are Isaksen; Jane R Deayton; Jane Anderson; Chloe Orkin; Andrew J Stagg; Aine McKnight
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

6.  Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1.

Authors:  Robert J Gifford; Tulio de Oliveira; Andrew Rambaut; Oliver G Pybus; David Dunn; Anne-Mieke Vandamme; Paul Kellam; Deenan Pillay
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

7.  Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.

Authors:  Georges Teto; Georgette D Kanmogne; Judith N Torimiro; George Alemnji; Flore N Nguemaim; Désiré Takou; Aubin Nanfack; Asonganyi Tazoacha
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

8.  Current status of HIV/AIDS in Cameroon: how effective are control strategies?

Authors:  Dora Mbanya; Martyn Sama; Paul Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2008-12       Impact factor: 3.390

9.  Field evaluation of Calypte's AWARE blood serum plasma (BSP) and oral mucosal transudate (OMT) rapid tests for detecting antibodies to HIV-1 and 2 in plasma and oral fluid.

Authors:  George A Alemnji; Gisele A Ngulefac; Peter M Ndumbe; Tazoacha Asonganyi
Journal:  Open AIDS J       Date:  2009-03-19

10.  Rapid detection of human immunodeficiency virus type 1 group M by a reverse transcription-loop-mediated isothermal amplification assay.

Authors:  Norimitsu Hosaka; Nicaise Ndembi; Azumi Ishizaki; Seiji Kageyama; Kei Numazaki; Hiroshi Ichimura
Journal:  J Virol Methods       Date:  2009-01-30       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.